DANIEL ESTES

Daniel Estes stands as a distinguished General Partner on the Growth Equity team at Frazier Healthcare Partners, a leading private equity firm dedicated exclusively to the healthcare industry. In his pivotal role, Mr. Estes is instrumental in shaping the firm's investment strategy and portfolio, focusing on growth equity opportunities that promise significant impact and returns within the dynamic healthcare landscape.

At Frazier Healthcare Partners, Daniel Estes's investment focus spans a broad spectrum of healthcare sub-sectors. He actively seeks out and invests in companies within healthcare services, healthcare information technology (IT), pharmaceutical services, and medical products. His expertise lies in identifying businesses with strong growth potential, robust management teams, and innovative solutions that address critical needs in the healthcare ecosystem. Through strategic capital deployment and active partnership, Estes helps these companies scale, innovate, and achieve their full market potential.

Mr. Estes's career trajectory showcases a deep commitment to and expertise in healthcare growth equity. He joined Frazier Healthcare Partners in 2008, bringing a wealth of experience from his previous roles. Prior to his tenure at Frazier, Daniel Estes honed his skills at Summit Partners, another respected growth equity firm, where he focused on healthcare investments. His foundational experience also includes investment banking at J.P. Morgan, providing him with a comprehensive understanding of financial markets and corporate strategy. Academically, Mr. Estes holds an MBA from the Stanford Graduate School of Business and a BA from Dartmouth College, solidifying his strong analytical and business acumen.

Throughout his career at Frazier Healthcare Partners, Daniel Estes has been involved in numerous notable investments and has served on the boards of several successful companies. His contributions have been vital to the growth and successful exits of portfolio companies such as MRO Corp (acquired by Verisk), Matrix Medical Network (acquired by Optum), and Laboratory Supply Company (acquired by McKesson). He has also played a key role in the development of companies like North American Dental Group, United Musculoskeletal Partners, Suncrest Hospice, and Caravel Autism Health, among others. These investments underscore his ability to identify and nurture companies that deliver significant value to both patients and investors, reinforcing his reputation as a key figure in healthcare private equity.